Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
November 30, 2006
Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer
S M Eschmann, G Friedel, F Paulsen, et al.
Pneumologie (Stuttgart, Germany)
|
January 2, 2001
[Pharmacokinetics of cyclophosphamide, adriamycin and adriamycin prodrug (HMR 1928) using an ex vivo isolated perfused human lung model (IHLP)]
T E Mürdter, A Linder, G Friedel, et al.
Cancer Chemotherapy and Pharmacology
|
January 27, 2000
Variability of cyclophosphamide uptake into human bronchial carcinoma: consequences for local bioactivation
F Bohnenstengel, G Friedel, C A Ritter, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
January 1, 1997
Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases
U Pastorino, M Buyse, G Friedel, et al.
Pneumologie (Stuttgart, Germany)
|
January 15, 2010
[Bronchial aspergillosis]
I Dobbertin, G Friedel, R Jaki, et al.
Acta Histochemica
|
August 12, 1999
Ligands for Viscum album agglutinin and galectin-1 in human lung cancer: is there any prognostic relevance?
P Fritz, R Seizer-Schmidt, T E Mürdter, et al.
Zentralblatt Fur Chirurgie
|
April 21, 1999
[Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases--the International Registry of Lung Metastases]
G Friedel, U Pastorino, M Buyse, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 5, 2005
Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?
S M Eschmann, G Friedel, F Paulsen, et al.
Cancer Research
|
June 15, 1997
Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site
T E Mürdter, B Sperker, K T Kivistö, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial
M Guberina, W Eberhardt, M Stuschke, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Lung Cancer (Amsterdam, Netherlands)
|
November 30, 2006
Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer
S M Eschmann, G Friedel, F Paulsen, et al.
Pneumologie (Stuttgart, Germany)
|
January 2, 2001
[Pharmacokinetics of cyclophosphamide, adriamycin and adriamycin prodrug (HMR 1928) using an ex vivo isolated perfused human lung model (IHLP)]
T E Mürdter, A Linder, G Friedel, et al.
Cancer Chemotherapy and Pharmacology
|
January 27, 2000
Variability of cyclophosphamide uptake into human bronchial carcinoma: consequences for local bioactivation
F Bohnenstengel, G Friedel, C A Ritter, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
January 1, 1997
Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases
U Pastorino, M Buyse, G Friedel, et al.
Pneumologie (Stuttgart, Germany)
|
January 15, 2010
[Bronchial aspergillosis]
I Dobbertin, G Friedel, R Jaki, et al.
Acta Histochemica
|
August 12, 1999
Ligands for Viscum album agglutinin and galectin-1 in human lung cancer: is there any prognostic relevance?
P Fritz, R Seizer-Schmidt, T E Mürdter, et al.
Zentralblatt Fur Chirurgie
|
April 21, 1999
[Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases--the International Registry of Lung Metastases]
G Friedel, U Pastorino, M Buyse, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 5, 2005
Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?
S M Eschmann, G Friedel, F Paulsen, et al.
Cancer Research
|
June 15, 1997
Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site
T E Mürdter, B Sperker, K T Kivistö, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2017
Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial
M Guberina, W Eberhardt, M Stuschke, et al.
Page
of 7